Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 3 (2006), Issue 9 (September)

1. Fruit and vegetable juices and Alzheimer's disease: the Kame Project.
   Am J Med, 119(9): 751-9. [Abstract] [Full-text]
2. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
   Am J Psychiatry, 163(9): 1603-10. [Abstract] [Full-text]
3. An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.
   Proc Natl Acad Sci U S A, 103(35): 13203-7. [Abstract] [Full-text]
4. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside.
   Behav Brain Res, 173(2): 246-54. [Abstract] [Full-text]
5. Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques.
   Hum Mutat, 27(10): 1063. [Abstract] [Full-text]
6. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
   Clin Pharmacol Ther, 80(3): 216-27. [Abstract] [Full-text]
7. Alzheimer's disease and anaesthesia: implications for the central cholinergic system.
   Br J Anaesth, 97(4): 445-52. [Abstract] [Full-text]
8. Combined cerebral blood flow effects of a cholinergic agonist (milameline) and a verbal recognition task in early Alzheimer's disease.
   Psychiatry Clin Neurosci, 60(5): 616-25. [Abstract] [Full-text]
9. Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.
   J Int Neuropsychol Soc, 12(5): 707-35. [Abstract] [Full-text]
10. Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome.
    Neurosci Lett, 406(3): 298-302. [Abstract] [Full-text]
11. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
    Neurosci Lett, 406(3): 189-93. [Abstract] [Full-text]
12. Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease.
    Neurosci Lett, 406(3): 265-9. [Abstract] [Full-text]
13. Association of metabolic syndrome with Alzheimer disease: a population-based study.
    Neurology, 67(5): 843-7. [Abstract] [Full-text]
14. Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.
    Neurology, 67(5): 830-3. [Abstract] [Full-text]
15. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Neuropathol Appl Neurobiol, 32(5): 539-56. [Abstract] [Full-text]
16. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
    Neuropathol Appl Neurobiol, 32(5): 505-16. [Abstract] [Full-text]
17. A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 77(10): 1116-21. [Abstract] [Full-text]
18. Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer's type and controls.
    J Neurol Neurosurg Psychiatry, 77(10): 1129-35. [Abstract] [Full-text]
19. Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease.
    Biochem Biophys Res Commun, 349(2): 634-42. [Abstract] [Full-text]
20. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?
    Neurobiol Aging, 27(11): 1618-31. [Abstract] [Full-text]
21. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.
    Neurobiol Aging, 27(11): 1613-7. [Abstract] [Full-text]
22. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Neurobiol Aging, 27(11): 1564-76. [Abstract] [Full-text]
23. Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease.
    Neurobiol Aging, 27(11): 1658-72. [Abstract] [Full-text]
24. The amyloid pathology progresses in a neurotransmitter-specific manner.
    Neurobiol Aging, 27(11): 1644-57. [Abstract] [Full-text]
25. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons.
    Neurobiol Aging, 27(11): 1577-87. [Abstract] [Full-text]
26. Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease.
    Neurobiol Aging, 27(11): 1537-53. [Abstract] [Full-text]
27. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms.
    Neurobiol Aging, 27(11): 1595-603. [Abstract] [Full-text]
28. Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease.
    Neurobiol Aging, 27(11): 1554-63. [Abstract] [Full-text]
29. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice.
    Neurobiol Aging, 27(11): 1632-43. [Abstract] [Full-text]
30. Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment.
    Neurobiol Aging, 27(11): 1604-12. [Abstract] [Full-text]
31. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease.
    Clin Neuropsychol, 20(4): 623-36. [Abstract] [Full-text]
32. Current strategies for the treatment of Alzheimer's disease and other tauopathies.
    Expert Opin Ther Targets, 10(5): 665-76. [Abstract] [Full-text]
33. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.
    Lancet Neurol, 5(10): 828-34. [Abstract] [Full-text]
34. Different patterns of Mini Mental Status Examination responses in primary progressive aphasia and Alzheimer's disease.
    Eur J Neurol, 13(10): 1124-7. [Abstract] [Full-text]
35. Differential attrition in a caregiver skill training trial.
    Res Nurs Health, 29(5): 498-506. [Abstract] [Full-text]
36. Quantitative MR imaging in Alzheimer disease.
    Radiology, 241(1): 26-44. [Abstract] [Full-text]
37. Brain mechanisms of successful compensation during learning in Alzheimer disease.
    Neurology, 67(6): 1011-7. [Abstract] [Full-text]
38. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.
    Neurology, 67(6): 1006-10. [Abstract] [Full-text]
39. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.
    Neurology, 67(6): 998-1005. [Abstract] [Full-text]
40. Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma.
    Neurobiol Dis, 24(1): 114-27. [Abstract] [Full-text]
41. Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma.
    Neurobiol Dis, 24(1): 89-100. [Abstract] [Full-text]
42. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus.
    Neurobiol Dis, 24(1): 1-14. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.